Relationship between absorbed dose and SUV derived from SPECT/CT imaging and dose-response in patients with neuroendocrine tumors treated with ¹⁷⁷LuLu-DOTA-TATE

Key Points

• This research investigates the relationship between absorbed doses and SUV from SPECT/CT imaging in patients treated for neuroendocrine tumors.
• Compared treatment outcomes of Lutetium-177 and Octreotide in patients with GEP-NETs.
• Utilized SPECT/CT imaging to measure absorbed dose and SUV.
• Analyzed dose-response relationships based on imaging results.
• Found significant correlations between absorbed dose and SUV.
• Indicated favorable responses in patients treated with Lutetium-177.
• Demonstrated improved treatment efficacy compared to Octreotide.